FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Newsom-Davis

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Miranda Payne; Penny Bradbury; Bethan Lang; Angela Vincent; Cheng Han; John Newsom-Davis; Denis C Talbot
Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
Marguerite E Hill; Hiroyuki Shiono; John Newsom-Davis; Nick Willcox
The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics.
Inmaculada B Aban; Gil I Wolfe; Gary R Cutter; Henry J Kaminski; Alfred Jaretzki; Greg Minisman; Robin Conwit; John Newsom-Davis
The MGTX experience: challenges in planning and executing an international, multicenter clinical trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Newsom-Davis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Miranda Payne; Penny Bradbury; Bethan Lang; Angela Vincent; Cheng Han; John Newsom-Davis; Denis C Talbot
Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(1):34-8.
2008: Marguerite E Hill; Hiroyuki Shiono; John Newsom-Davis; Nick Willcox
The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics.
Journal of neuroimmunology 2008;201-202():50-6.
2008: Inmaculada B Aban; Gil I Wolfe; Gary R Cutter; Henry J Kaminski; Alfred Jaretzki; Greg Minisman; Robin Conwit; John Newsom-Davis
The MGTX experience: challenges in planning and executing an international, multicenter clinical trial.
Journal of neuroimmunology 2008;201-202():80-4.
2008: CA MacLennan; Angela Vincent; Alexander Marx; Nick Willcox; Nils Eric Gilhus; John Newsom-Davis; David Beeson
Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis.
Journal of neuroimmunology 2008;201-202():28-32.
2008: Philipp Ströbel; Regina Moritz; Maria Isabel Leite; Nick Willcox; Wen-Yu Chuang; Ralf Gold; Wilfred Nix; Berthold Schalke; Reinhard Kiefer; Hans Konrad Müller-Hermelink; Alfred Jaretzki Iii; John Newsom-Davis; Alexander Marx
The ageing and myasthenic thymus: a morphometric study validating a standard procedure in the histological workup of thymic specimens.
Journal of neuroimmunology 2008;201-202():64-73.
2008: John Newsom-Davis; Gary R Cutter; Gil I Wolfe; Henry J Kaminski; Alfred Jaretzki; Greg Minisman; Inmaculada B Aban; Robin Conwit
Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone.
Annals of the New York Academy of Sciences 2008;1132():344-7.
2008: David Beeson; Richard Webster; Judy Cossins; Daniel Lashley; Hayley Spearman; Susan Maxwell; Clarke Slater; John Newsom-Davis; Jacqueline Palace; Angela Vincent
Congenital myasthenic syndromes and the formation of the neuromuscular junction.
Annals of the New York Academy of Sciences 2008;1132():99-103.
2008: Angela Vincent; Maria Isabel Leite; Maria Elena Farrugia; Saiju Jacob; Stuart Viegas; Hiro Shiraishi; Olivier Benveniste; B Paul Morgan; David Hilton-Jones; John Newsom-Davis; David Beeson; Nick Willcox
Myasthenia gravis seronegative for acetylcholine receptor antibodies.
Annals of the New York Academy of Sciences 2008;1132():84-92.
2007: Jacqueline Palace; Daniel Lashley; John Newsom-Davis; Judy Cossins; Susan Maxwell; Robin P Kennett; Sandeep Jayawant; Yuji Yamanashi; David Beeson
Clinical features of the DOK7 neuromuscular junction synaptopathy.
Brain : a journal of neurology 2007;130(Pt 6):1507-15.
2007: Maria Elena Farrugia; Robin P Kennett; David Hilton-Jones; John Newsom-Davis; Angela Vincent
Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2007;118(2):269-77.
2006: John Newsom-Davis
Neuromyotonia: a diverse disorder.
Neurology India 2006;54(4):350.
2006: David Beeson; Osamu Higuchi; Jacqueline Palace; Judy Cossins; Hayley Spearman; Susan Maxwell; John Newsom-Davis; Georgina Burke; Peter R W Fawcett; Masakatsu Motomura; Juliane S Müller; Hanns Lochmüller; Clarke Slater; Angela Vincent; Yuji Yamanashi
Dok-7 mutations underlie a neuromuscular junction synaptopathy.
Science (New York, N.Y.) 2006;313(5795):1975-8.
2006: Maria Elena Farrugia; Matthew D Robson; Linda Clover; Phil Anslow; John Newsom-Davis; Robin P Kennett; David Hilton-Jones; Paul Matthews; Angela Vincent
MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Brain : a journal of neurology 2006;129(Pt 6):1481-92.
2006: Paul Maddison; Kerry R Mills; John Newsom-Davis
Clinical electrophysiological characterization of the acquired neuromyotonia phenotype of autoimmune peripheral nerve hyperexcitability.
Muscle & nerve 2006;33(6):801-8.
2006: Maria Elena Farrugia; Robin P Kennett; John Newsom-Davis; David Hilton-Jones; Angela Vincent
Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis.
Muscle & nerve 2006;33(4):568-70.
2006: Suthipun Jitpimolmard; Somsak Taimkao; Verajit Chotmongkol; Kittisak Sawanyawisuth; Angela Vincent; John Newsom-Davis
Acetylcholine receptor antibody in Thai generalized myasthenia gravis patients.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2006;89(1):68-71.
2005: John Newsom-Davis
Neuromuscular junction channelopathies: a brief overview.
Acta neurologica Belgica 2005;105(4):181-6.
2005: John Newsom-Davis
Can tacrolimus replace ciclosporin and prednisone to treat myasthenia gravis?
Nature clinical practice. Neurology 2005;1(1):14-5.
2005: Maria Isabel Leite; Philipp Ströbel; Margaret Jones; Kingsley Micklem; Regina Moritz; Ralf Gold; Erik H Niks; Sonia Berrih-Aknin; Francesco Scaravilli; Aurea Canelhas; Alexander Marx; John Newsom-Davis; Nick Willcox; Angela Vincent
Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
Annals of neurology 2005;57(3):444-8.
2005: Angela C Vincent; John McConville; John Newsom-Davis
Is "seronegative" MG explained by autoantibodies to MuSK?
Neurology 2005;64(2):399; author reply 399.
2004: Georgina Burke; Judy Cossins; Susan Maxwell; S Robb; M Nicolle; Angela Vincent; John Newsom-Davis; Jacqueline Palace; David Beeson
Distinct phenotypes of congenital acetylcholine receptor deficiency.
Neuromuscular disorders : NMD 2004;14(6):356-64.
2004: John Newsom-Davis
Neuromyotonia.
Revue neurologique 2004;160(5 Pt 2):S85-9.
2004: Richard Webster; Martin Brydson; Rebecca Croxen; John Newsom-Davis; Angela Vincent; David Beeson
Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome.
Neurology 2004;62(7):1090-6.
2004: John McConville; Maria Elena Farrugia; David Beeson; Uday Kishore; Richard Metcalfe; John Newsom-Davis; Angela Vincent
Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
Annals of neurology 2004;55(4):580-4.
2004: Angela Vincent; John McConville; Maria Elena Farrugia; John Newsom-Davis
Seronegative myasthenia gravis.
Seminars in neurology 2004;24(1):125-33.
2004: John Newsom-Davis
Lambert-Eaton myasthenic syndrome.
Revue neurologique 2004;160(2):177-80.
2003: Georgina Burke; Judy Cossins; Susan Maxwell; G Owens; Angela Vincent; S Robb; M Nicolle; D Hilton-Jones; John Newsom-Davis; Jacqueline Palace; David Beeson
Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes.
Neurology 2003;61(6):826-8.
2003: Gil I Wolfe; Henry J Kaminski; Alfred Jaretzki; Anthony Swan; John Newsom-Davis
Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapy.
Annals of the New York Academy of Sciences 2003;998():473-80.
2003: Angela Vincent; John McConville; Maria Elena Farrugia; John Bowen; Paul Plested; Teresa Tang; Amelia Evoli; Ian Matthews; Gary P Sims; Paola Dalton; Leslie Jacobson; Agata Polizzi; Frans Blaes; Bethan Lang; David Beeson; Nick Willcox; John Newsom-Davis; Werner Hoch
Antibodies in myasthenia gravis and related disorders.
Annals of the New York Academy of Sciences 2003;998():324-35.
2003: John Newsom-Davis; Camilla Buckley; Linda Clover; Ian Hart; Paul Maddison; Erdem Tüzüm; Angela Vincent
Autoimmune disorders of neuronal potassium channels.
Annals of the New York Academy of Sciences 2003;998():202-10.
2003: Paul W Wirtz; Nick Willcox; Bart O Roep; Bethan Lang; Axel R Wintzen; John Newsom-Davis; Jan J Verschuuren
HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma.
Annals of the New York Academy of Sciences 2003;998():200-1.
2003: Bethan Lang; Ashwin Pinto; Federica Giovannini; John Newsom-Davis; Angela Vincent
Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
Annals of the New York Academy of Sciences 2003;998():187-95.
2003: David Beeson; Richard Webster; John Ealing; Rebecca Croxen; Sharon Brownlow; Martin Brydson; John Newsom-Davis; Clarke Slater; Chris Hatton; Chris Shelley; David Colquhoun; Angela Vincent
Structural abnormalities of the AChR caused by mutations underlying congenital myasthenic syndromes.
Annals of the New York Academy of Sciences 2003;998():114-24.
2003: John Newsom-Davis
Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
Seminars in neurology 2003;23(2):191-8.
2003: Wei Zhang; Jian-Li Liu; Anthony Meager; John Newsom-Davis; Nick Willcox
Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-gamma responses of healthy CD4+ T cells.
Journal of neuroimmunology 2003;139(1-2):102-8.
2003: Angela Vincent; John Bowen; John Newsom-Davis; John McConville
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.
Lancet neurology 2003;2(2):99-106.
2002: Ian K Hart; Paul Maddison; John Newsom-Davis; Angela Vincent; Kerry R Mills
Phenotypic variants of autoimmune peripheral nerve hyperexcitability.
Brain : a journal of neurology 2002;125(Pt 8):1887-95.
2002: Rebecca Croxen; Chris Hatton; Chris Shelley; Martin Brydson; G Chauplannaz; Hans Oosterhuis; Angela Vincent; John Newsom-Davis; David Colquhoun; David Beeson
Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes.
Neurology 2002;59(2):162-8.
2002: Rebecca Croxen; Angela Vincent; John Newsom-Davis; David Beeson
Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutations.
Neurology 2002;58(10):1563-5.
2002: Roger Rosenberg; Michael Aminoff; François Boller; Per Soelberg Soerensen; Robert C Griggs; vladimir hachinski; Mark Hallett; Richard T Johnson; Christopher Kennard; Anthony E Lang; Andrew J Lees; Robert P Lisak; John Newsom-Davis; Timothy A Pedley; Michael E Selzer; Douglas W Zochodne
Reporting clinical trials: full access to all the data. Author's right to access to all data obtained in their study.
Journal of neurology 2002;249(5):638-9.
2002: Ashwin Pinto; Kazuo Iwasa; Claire Newland; John Newsom-Davis; Bethan Lang
The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
Muscle & nerve 2002;25(5):715-24.
2002: Ioannis Roxanis; Kingsley Micklem; John McConville; John Newsom-Davis; Nick Willcox
Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis.
Journal of neuroimmunology 2002;125(1-2):185-97.
2002: Roger Rosenberg; Michael Aminoff; François Boller; Per Soelberg Sørensen; Robert C Griggs; Mark Hallett; Richard T Johnson; vladimir hachinski; Christopher Kennard; Anthony E Lang; Andrew J Lees; Robert P Lisak; John Newsom-Davis; Timothy A Pedley; Michael E Selzer; Douglas W Zochodne
Reporting clinical trials: full access to all the data.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2002;9(2):123-4.
2002: Roger Rosenberg; Michael Aminoff; François Boller; Per Soelberg Soerensen; Robert C Griggs; vladimir hachinski; Mark Hallett; Richard T Johnson; Christopher Kennard; Anthony E Lang; Andrew J Lees; Robert P Lisak; John Newsom-Davis; Timothy A Pedley; Michael E Selzer; Douglas W Zochodne
Reporting clinical trials: full access to all the data.
Brain : a journal of neurology 2002;125(Pt 3):i-ii.
2002: Roger Rosenberg; Michael Aminoff; François Boller; P S Sørenson; Robert C Griggs; vladimir hachinski; Mark Hallett; Richard T Johnson; Christopher Kennard; Anthony E Lang; Andrew J Lees; Robert P Lisak; John Newsom-Davis; Timothy A Pedley; Michael E Selzer; Douglas W Zochodne
Reporting clinical trials: full access to all the data.
Neurology 2002;58(3):347-8.
2002: Roger Rosenberg; Michael J Aminoff; François Boller; Per Soelberg Soerensen; Robert C Griggs; vladimir hachinski; Mark Hallett; Richard T Johnson; Christopher Kennard; Anthony E Lang; Andrew J Lees; Robert P Lisak; John Newsom-Davis; Timothy A Pedley; Michael E Selzer; Douglas W Zochodne
Reporting clinical trials: full access to all the data.
Muscle & nerve 2002;25(2):133-4.
2002: Roger Rosenberg; M Aminoff; F BoIler; Per Soelberg Soerensen; R C Griggs; vladimir hachinski; Mark Hallett; Richard T Johnson; C Kennard; Anthony E Lang; A J Lees; Robert P Lisak; John Newsom-Davis; Timothy A Pedley; M E SeIzer; D Zochodne
Reporting clinical trials: full access to all the data.
Journal of neurology, neurosurgery, and psychiatry 2002;72(2):143.
2002: Roger Rosenberg; Michael Aminoff; François Boller; Per Soelberg Soerensen; Robert C Griggs; Mark Hallett; vladimir hachinski; Richard T Johnson; Christopher Kennard; Anthony E Lang; Andrew J Lees; Robert P Lisak; John Newsom-Davis; Timothy A Pedley; Michael E Selzer; Douglas W Zochodne
Reporting clinical trials: full access to all the data.
Movement disorders : official journal of the Movement Disorder Society 2002;17(1):3-4.
2002: Roger Rosenberg; Michael Aminoff; François Boller; Per Soelberg Soerensen; Robert C Griggs; vladimir hachinski; Mark Hallett; Richard T Johnson; Christopher Kennard; Anthony E Lang; Andrew J Lees; Robert P Lisak; John Newsom-Davis; Timothy A Pedley; Michael E Selzer; Douglas W Zochodne
Reporting clinical trials: full access to all of the data.
Archives of neurology 2002;59(1):27-8.
2001: Camilla Buckley; John Newsom-Davis; Nick Willcox; Angela Vincent
Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?
Neurology 2001;57(9):1579-82.
2001: Camilla Buckley; D Douek; John Newsom-Davis; Angela Vincent; Nick Willcox
Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis.
Annals of neurology 2001;50(1):64-72.
2001: Sharon Brownlow; Richard Webster; Rebecca Croxen; Martin Brydson; B Neville; Jean-Pierre Lin; Angela Vincent; John Newsom-Davis; David Beeson
Acetylcholine receptor delta subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita.
The Journal of clinical investigation 2001;108(1):125-30.
2001: Werner Hoch; John McConville; Sigrun Helms; John Newsom-Davis; Arthur Melms; Angela Vincent
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
Nature medicine 2001;7(3):365-8.
2001: Paul Maddison; B Lang; K Mills; John Newsom-Davis
Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
Journal of neurology, neurosurgery, and psychiatry 2001;70(2):212-7.
2001: Roger Rosenberg; Michael Aminoff; François Boller; Per Soelberg Soerensen; Robert C Griggs; Mark Hallett; Richard T Johnson; Christopher Kennard; Anthony E Lang; Andrew J Lees; Robert P Lisak; John Newsom-Davis; Timothy A Pedley; Michael E Selzer; Douglas W Zochodne
Reporting clinical trials: full access to all the data.
Neurorehabilitation and neural repair 2001;15(3):157-8.
1999: FY Li; M Tariq; Rebecca Croxen; K Morten; W Squier; John Newsom-Davis; David Beeson; Catharina Larsson
Mapping of autosomal dominant progressive external ophthalmoplegia to a 7-cM critical region on 10q24.
Neurology 1999;53(6):1265-71.
1999: Rebecca Croxen; Claire Newland; M Betty; Angela Vincent; John Newsom-Davis; David Beeson
Novel functional epsilon-subunit polypeptide generated by a single nucleotide deletion in acetylcholine receptor deficiency congenital myasthenic syndrome.
Annals of neurology 1999;46(4):639-47.
1999: M Janer; A Cowland; J Picard; D Campbell; P Pontarotti; John Newsom-Davis; Mike Bunce; K Welsh; A Demaine; A G Wilson; Nick Willcox
A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C.
Human immunology 1999;60(9):909-17.
1999: Paul Maddison; John Newsom-Davis; Kerry R Mills
Strength-duration properties of peripheral nerve in acquired neuromyotonia.
Muscle & nerve 1999;22(7):823-30.
1999: M E Hill; D J Ferguson; Jonathan M Austyn; John Newsom-Davis; H N Willcox
Potent immunostimulatory dendritic cells can be cultured in bulk from progenitors in normal infant and adult myasthenic human thymus.
Immunology 1999;97(2):325-32.
1999: M Hill; P Moss; Paul Wordsworth; John Newsom-Davis; Nick Willcox
T cell responses to D-penicillamine in drug-induced myasthenia gravis: recognition of modified DR1:peptide complexes.
Journal of neuroimmunology 1999;97(1-2):146-53.
1999: John Newsom-Davis
Paraneoplastic neurological disorders.
Journal of the Royal College of Physicians of London 1999;33(3):225-7.
1999: P Nichols; Rebecca Croxen; Angela Vincent; R Rutter; Michael Hutchinson; John Newsom-Davis; David Beeson
Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome.
Annals of neurology 1999;45(4):439-43.
1999: M Hill; David Beeson; P Moss; Leslie Jacobson; A Bond; Louise Corlett; John Newsom-Davis; Angela Vincent; Nick Willcox
Early-onset myasthenia gravis: a recurring T-cell epitope in the adult-specific acetylcholine receptor epsilon subunit presented by the susceptibility allele HLA-DR52a.
Annals of neurology 1999;45(2):224-31.
1999: Paul Maddison; John Newsom-Davis; Kerry R Mills; R L Souhami
Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.
Lancet 1999;353(9147):117-8.
1999: John Newsom-Davis
Autoimmune syndromes at the neuromuscular junction.
Journal of child neurology 1999;14(1):41-3.
1998: Paul Maddison; John Newsom-Davis; Kerry R Mills
Effect of 3,4-diaminopyridine on the time course of decay of compound muscle action potential augmentation in the Lambert-Eaton myasthenic syndrome.
Muscle & nerve 1998;21(9):1196-8.
1998: Paul Maddison; John Newsom-Davis; Kerry R Mills
Distribution of electrophysiological abnormality in Lambert-Eaton myasthenic syndrome.
Journal of neurology, neurosurgery, and psychiatry 1998;65(2):213-7.
1998: Ashwin Pinto; SE Gillard; Fraser Moss; K Whyte; P Brust; M Williams; K Stauderman; Michael M Harpold; Bethan Lang; John Newsom-Davis; David Bleakman; D Lodge; J Boot
Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(14):8328-33.
1998: Jacqueline Palace; John Newsom-Davis; B Lecky
A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
Neurology 1998;50(6):1778-83.
1998: AM Moody; H Reyburn; Nick Willcox; John Newsom-Davis
New polymorphism of the human T-cell receptor AV28S1 gene segment.
Immunogenetics 1998;48(1):62-4.
1998: N Nagvekar; AM Moody; P Moss; Ioannis Roxanis; J Curnow; David Beeson; N Pantic; John Newsom-Davis; Angela Vincent; Nick Willcox
A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.
The Journal of clinical investigation 1998;101(10):2268-77.
1998: John Newsom-Davis
A treatment algorithm for Lambert-Eaton myasthenic syndrome.
Annals of the New York Academy of Sciences 1998;841():817-22.
1998: Ashwin Pinto; Fraser Moss; Bethan Lang; J Boot; P Brust; M Williams; K Stauderman; Michael M Harpold; John Newsom-Davis
Differential effect of Lambert-Eaton myasthenic syndrome immunoglobulin on cloned neuronal voltage-gated calcium channels.
Annals of the New York Academy of Sciences 1998;841():687-90.
1998: Agata Polizzi; Bethan Lang; Elisabeth Amyes; John Newsom-Davis; Angela Vincent
Neuronal staining patterns in sera from patients with Lambert-Eaton myasthenic syndrome.
Annals of the New York Academy of Sciences 1998;841():684-6.
1998: Bethan Lang; S Waterman; Ashwin Pinto; D Jones; Fraser Moss; J Boot; P Brust; M Williams; K Stauderman; Michael M Harpold; M Motomura; J W Moll; Angela Vincent; John Newsom-Davis
The role of autoantibodies in Lambert-Eaton myasthenic syndrome.
Annals of the New York Academy of Sciences 1998;841():596-605.
1998: C P Plested; John Newsom-Davis; Angela Vincent
Seronegative myasthenia plasmas and non-IgG fractions transiently inhibit nAChR function.
Annals of the New York Academy of Sciences 1998;841():501-4.
1998: Angela Vincent; Leslie Jacobson; Paul Plested; Agata Polizzi; Teresa Tang; S Riemersma; Claire Newland; S Ghorazian; J Farrar; CA MacLennan; Nick Willcox; David Beeson; John Newsom-Davis
Antibodies affecting ion channel function in acquired neuromyotonia, in seropositive and seronegative myasthenia gravis, and in antibody-mediated arthrogryposis multiplex congenita.
Annals of the New York Academy of Sciences 1998;841():482-96.
1998: Ian Matthews; Jeremy Farrar; S McLachlan; B Rapoport; John Newsom-Davis; Nick Willcox; Angela Vincent
Production of Fab fragments against the human acetylcholine receptor from myasthenia gravis thymus lambda and kappa phage libraries.
Annals of the New York Academy of Sciences 1998;841():418-21.
1998: Y Liyanage; M Teo; CA MacLennan; A Buckel; David Beeson; Nick Willcox; John Newsom-Davis; Angela Vincent
Expression of muscle proteins in thymomas of patients with myasthenia gravis.
Annals of the New York Academy of Sciences 1998;841():411-3.
1998: CA MacLennan; David Beeson; Nick Willcox; Angela Vincent; John Newsom-Davis
Muscle nicotinic acetylcholine receptor mRNA expression in hyperplastic and neoplastic myasthenia gravis thymus.
Annals of the New York Academy of Sciences 1998;841():407-10.
1998: David Beeson; A P Bond; Louise Corlett; SJ Curnow; M E Hill; LW Jacobson; CA MacLennan; Anthony Meager; AM Moody; P Moss; N Nagvekar; John Newsom-Davis; N Pantic; Ioannis Roxanis; EG Spack; Angela Vincent; Nick Willcox
Thymus, thymoma, and specific T cells in myasthenia gravis.
Annals of the New York Academy of Sciences 1998;841():371-87.
1998: Rebecca Croxen; David Beeson; Claire Newland; M Betty; Angela Vincent; John Newsom-Davis
A single nucleotide deletion in the epsilon subunit of the acetylcholine receptor (AChR) in five congenital myasthenic syndrome patients with AChR deficiency.
Annals of the New York Academy of Sciences 1998;841():195-8.
1998: David Beeson; Claire Newland; Rebecca Croxen; A Buckel; F Y Li; C Larsson; M Tariq; Angela Vincent; John Newsom-Davis
Congenital myasthenic syndromes. Studies of the AChR and other candidate genes.
Annals of the New York Academy of Sciences 1998;841():181-3.
1998: Paul Maddison; John Newsom-Davis; Kerry R Mills
Decay of postexercise augmentation in the Lambert-Eaton myasthenic syndrome: effect of cooling.
Neurology 1998;50(4):1083-7.
1998: A P Bond; Louise Corlett; SJ Curnow; EG Spack; Nick Willcox; John Newsom-Davis
Diverse patterns of unresponsiveness in an acetylcholine receptor-specific T-cell clone from a myasthenia gravis patient after engaging the T-cell receptor with three different ligands.
Journal of neuroimmunology 1998;82(2):182-90.
1998: John Newsom-Davis
Autoimmune and genetic disorders at the neuromuscular junction. The 1997 Ronnie Mac Keith lecture.
Developmental medicine and child neurology 1998;40(3):199-206.
1997: John Newsom-Davis
Autoimmune neuromyotonia (Isaacs' syndrome): an antibody-mediated potassium channelopathy.
Annals of the New York Academy of Sciences 1997;835():111-9.
1997: Clarke Slater; Carol Young; S J Wood; Guy S Bewick; Louise V B Anderson; P Baxter; Peter R W Fawcett; M Roberts; L Jacobson; J Kuks; A Vincent; John Newsom-Davis
Utrophin abundance is reduced at neuromuscular junctions of patients with both inherited and acquired acetylcholine receptor deficiencies.
Brain : a journal of neurology 1997;120 ( Pt 9)():1513-31.
1997: Jeremy Farrar; S Portolano; Nick Willcox; Angela Vincent; Leslie Jacobson; John Newsom-Davis; B Rapoport; S M McLachlan
Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library.
International immunology 1997;9(9):1311-8.
1997: M Hanna; K Mills; L Pazdera; John Newsom-Davis
Primary orthostatic tremor with prominent muscle hypertrophy.
Neurology 1997;49(3):872-4.
1997: S A Waterman; Bethan Lang; John Newsom-Davis
Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
Annals of neurology 1997;42(2):147-56.
1997: A Bond; Louise Corlett; N Nagvekar; Leslie Jacobson; N Pantic; David Beeson; M Nicolle; Angela Vincent; John Newsom-Davis; EG Spack; Nick Willcox
Heterogeneity and immunotherapy of specific T-cells in myasthenia gravis.
Biochemical Society transactions 1997;25(2):665-70.
1997: Rebecca Croxen; Claire Newland; David Beeson; Hans Oosterhuis; G Chauplannaz; Angela Vincent; John Newsom-Davis
Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome.
Human molecular genetics 1997;6(5):767-74.
1997: CA MacLennan; David Beeson; A M Buijs; Angela Vincent; John Newsom-Davis
Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis.
Annals of neurology 1997;41(4):423-31.
1997: M Motomura; Bethan Lang; I Johnston; J Palace; Angela Vincent; John Newsom-Davis
Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Journal of the neurological sciences 1997;147(1):35-42.
1997: I K Hart; C Waters; Angela Vincent; Claire Newland; David Beeson; O Pongs; C Morris; John Newsom-Davis
Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia.
Annals of neurology 1997;41(2):238-46.
1996: David Beeson; Leslie Jacobson; John Newsom-Davis; Angela Vincent
A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis.
Neurology 1996;47(6):1552-5.
1996: S Riemersma; Angela Vincent; David Beeson; Claire Newland; S Hawke; B Vernet-der Garabedian; B Eymard; John Newsom-Davis
Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function.
The Journal of clinical investigation 1996;98(10):2358-63.
1996: P G Bain; M Motomura; John Newsom-Davis; S A Misbah; Helen Chapel; M L Lee; Angela Vincent; Bethan Lang
Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Neurology 1996;47(3):678-83.
1996: A Buckel; David Beeson; Angela Vincent; John Newsom-Davis
Cloning and expression of human S-laminin.
Biochemical Society transactions 1996;24(2):278S.
1996: A Glennerster; J Palace; D Warburton; S Oxbury; John Newsom-Davis
Memory in myasthenia gravis: neuropsychological tests of central cholinergic function before and after effective immunologic treatment.
Neurology 1996;46(4):1138-42.
1996: jeannine m heckmann; Karen E Morrison; Barbara Emeryk-Szajewska; H Strugalska; J Bergoffen; Nick Willcox; John Newsom-Davis
Human muscle acetylcholine receptor alpha-subunit gene (CHRNA1) association with autoimmune myasthenia gravis in black, mixed-ancestry and Caucasian subjects.
Journal of autoimmunity 1996;9(2):175-80.
1996: David Beeson; M Amar; Isabel Bermudez; Angela Vincent; John Newsom-Davis
Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the epsilon subunit.
Neuroscience letters 1996;207(1):57-60.
1995: Claire Newland; David Beeson; Angela Vincent; John Newsom-Davis
Functional and non-functional isoforms of the human muscle acetylcholine receptor.
The Journal of physiology 1995;489 ( Pt 3)():767-78.
1995: John Newsom-Davis
The Hughlings Jackson Lecture: autoimmunity and the nervous system.
Journal of the Royal Society of Medicine 1995;88(11):639P-643P.
1995: H Matsuo; A P Batocchi; S Hawke; M Nicolle; Leslie Jacobson; Angela Vincent; John Newsom-Davis; Nick Willcox
Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(7):3683-92.
1995: M Roberts; H J Willison; Angela Vincent; John Newsom-Davis
Multifocal motor neuropathy human sera block distal motor nerve conduction in mice.
Annals of neurology 1995;38(1):111-8.
1995: Angela Vincent; Claire Newland; Louise A Brueton; David Beeson; S Riemersma; SM Huson; John Newsom-Davis
Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen.
Lancet 1995;346(8966):24-5.
1995: N E Gilhus; M Jones; H Turley; K C Gatter; N Nagvekar; John Newsom-Davis; Nick Willcox
Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen.
Journal of clinical pathology 1995;48(5):447-55.
1995: M Motomura; I Johnston; Bethan Lang; Angela Vincent; John Newsom-Davis
An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.
Journal of neurology, neurosurgery, and psychiatry 1995;58(1):85-7.
1995: N E Gilhus; Nick Willcox; G Harcourt; N Nagvekar; David Beeson; Angela Vincent; John Newsom-Davis
Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells.
Journal of neuroimmunology 1995;56(1):65-76.
1995: P R Barnes; D J Kanabar; Louise A Brueton; John Newsom-Davis; SM Huson; N P Mann; David Hilton-Jones
Recurrent congenital arthrogryposis leading to a diagnosis of myasthenia gravis in an initially asymptomatic mother.
Neuromuscular disorders : NMD 1995;5(1):59-65.
1995: Angela Vincent; M Roberts; H Willison; Bethan Lang; John Newsom-Davis
Autoantibodies, neurotoxins and the nervous system.
Journal of physiology, Paris 1995;89(3):129-36.
1995: Bethan Lang; John Newsom-Davis
Immunopathology of the Lambert-Eaton myasthenic syndrome.
Springer seminars in immunopathology 1995;17(1):3-15.
1994: J Burges; Angela Vincent; P C Molenaar; John Newsom-Davis; C Peers; D Wray
Passive transfer of seronegative myasthenia gravis to mice.
Muscle & nerve 1994;17(12):1393-400.
1994: M Betty; David Beeson; L West; Angela Vincent; John Newsom-Davis
D17S1175: dinucleotide repeat polymorphism 5' to CHRNE.
Human molecular genetics 1994;3(11):2083.
1994: R Barrett-Jolley; N Byrne; Angela Vincent; John Newsom-Davis
Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line.
Pflügers Archiv : European journal of physiology 1994;428(5-6):492-8.
1994: M W Nicolle; B Nag; S D Sharma; Nick Willcox; Angela Vincent; D J Ferguson; John Newsom-Davis
Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.
The Journal of clinical investigation 1994;93(4):1361-9.
1994: M Roberts; H Willison; Angela Vincent; John Newsom-Davis
Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release.
Lancet 1994;343(8895):454-5.
1994: I Johnston; Bethan Lang; K Leys; John Newsom-Davis
Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
Neurology 1994;44(2):334-8.
1994: S Ratanachaiyavong; D Fleming; M Janer; Andrew G Demaine; Nick Willcox; John Newsom-Davis; Alan M McGregor
HLA-DPB1 polymorphisms in patients with hyperthyroid Graves' disease and early onset myasthenia gravis.
Autoimmunity 1994;17(2):99-104.
1994: Jacqueline Palace; Angela Vincent; David Beeson; John Newsom-Davis
Immunogenicity of human recombinant acetylcholine receptor alpha subunit: cytoplasmic epitopes dominate the antibody response in four mouse strains.
Autoimmunity 1994;18(2):113-9.
1993: A S Wierzbicki; David Beeson; Bethan Lang; John Newsom-Davis
Tissue-specific expression of putative domains of the mouse neuronal alpha-2 and delta genes of the voltage-gated calcium channel in rodent tissues.
Annals of the New York Academy of Sciences 1993;707():472-5.
1993: M J Thomas; S A Misbah; Helen Chapel; M Jones; G Elrington; John Newsom-Davis
Hemolysis after high-dose intravenous Ig.
Blood 1993;82(12):3789.
1993: CA MacLennan; David Beeson; Angela Vincent; John Newsom-Davis
Human nicotinic acetylcholine receptor alpha-subunit isoforms: origins and expression.
Nucleic acids research 1993;21(23):5463-7.
1993: G Harcourt; A P Batocchi; S Hawke; David Beeson; N Pantic; Leslie Jacobson; Nick Willcox; Angela Vincent; John Newsom-Davis
Detection of alpha-subunit isoforms in human muscle acetylcholine receptor by specific T cells from a myasthenia gravis patient.
Proceedings. Biological sciences / The Royal Society 1993;254(1339):1-6.
1993: David Beeson; M Brydson; M Betty; Steve Jeremiah; Sue Povey; Angela Vincent; John Newsom-Davis
Primary structure of the human muscle acetylcholine receptor. cDNA cloning of the gamma and epsilon subunits.
European journal of biochemistry / FEBS 1993;215(2):229-38.
1993: F Baggi; M Nicolle; Angela Vincent; H Matsuo; Nick Willcox; John Newsom-Davis
Presentation of endogenous acetylcholine receptor epitope by an MHC class II-transfected human muscle cell line to a specific CD4+ T cell clone from a myasthenia gravis patient.
Journal of neuroimmunology 1993;46(1-2):57-65.
1993: Angela Vincent; Z Li; A Hart; R Barrett-Jolley; T Yamamoto; J Burges; D Wray; N Byrne; P Molenaar; John Newsom-Davis
Seronegative myasthenia gravis. Evidence for plasma factor(s) interfering with acetylcholine receptor function.
Annals of the New York Academy of Sciences 1993;681():529-38.
1993: A S Wierzbicki; David Beeson; Bethan Lang; John Newsom-Davis
The tissue distribution of alpha 2-delta subunit genes of the voltage-gated calcium channel in rodent tissues and NG108-15 cells.
Annals of the New York Academy of Sciences 1993;681():422-4.
1993: M W Nicolle; Angela Vincent; S Sharma; B Nag; Nick Willcox; John Newsom-Davis
An in vitro model for disease-specific immunotherapy in myasthenia gravis using soluble MHC class II bound to AChR-derived peptide.
Annals of the New York Academy of Sciences 1993;681():577-80.
1993: Leslie Jacobson; Angela Vincent; P Shillito; John Newsom-Davis
EAMG induced in rabbits by immunization against peptides representing human AChR alpha 138-199.
Annals of the New York Academy of Sciences 1993;681():295-7.
1993: S Hawke; Nick Willcox; G Harcourt; Angela Vincent; John Newsom-Davis
Stimulation of specific T cells by human AChR adsorbed to immunomagnetic particles.
Annals of the New York Academy of Sciences 1993;681():288-91.
1993: A P Batocchi; G Harcourt; David Beeson; N Pantic; S Hawke; Nick Willcox; John Newsom-Davis
Differential recognition by T cells of the P3A+ and P3A- isoforms of the human acetylcholine receptor alpha-subunit.
Annals of the New York Academy of Sciences 1993;681():280-2.
1993: David Beeson; Angela Vincent; A Morris; M Brydson; Leslie Jacobson; F Baggi; Steve Jeremiah; Sue Povey; John Newsom-Davis
cDNA and genomic clones encoding the human muscle acetylcholine receptor.
Annals of the New York Academy of Sciences 1993;681():165-7.
1993: Angela Vincent; John Newsom-Davis; D Wray; P Shillito; J Harrison; M Betty; David Beeson; K Mills; Jacqueline Palace; P Molenaar
Clinical and experimental observations in patients with congenital myasthenic syndromes.
Annals of the New York Academy of Sciences 1993;681():451-60.
1993: Fulvio Baggi; Renato Mantegazza; Angela Vincent; John Newsom-Davis
HLA-A2-restricted T-cell line recognizing an epitope of the human acetylcholine receptor.
Annals of the New York Academy of Sciences 1993;681():276-9.
1993: P K Panegyres; M Squier; K R Mills; John Newsom-Davis
Acute myopathy associated with large parenteral dose of corticosteroid in myasthenia gravis.
Journal of neurology, neurosurgery, and psychiatry 1993;56(6):702-4.
1993: P Shillito; Angela Vincent; John Newsom-Davis
Congenital myasthenic syndromes.
Neuromuscular disorders : NMD 1993;3(3):183-90.
1993: John Newsom-Davis; K R Mills
Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review.
Brain : a journal of neurology 1993;116 ( Pt 2)():453-69.
1992: S Hawke; Nick Willcox; G Harcourt; Angela Vincent; John Newsom-Davis
Stimulation of human T cells by sparse antigens captured on immunomagnetic particles.
Journal of immunological methods 1992;155(1):41-8.
1992: C S Morris; Margaret M Esiri; A Marx; John Newsom-Davis
Immunocytochemical characteristics of small cell lung carcinoma associated with the Lambert-Eaton myasthenic syndrome.
The American journal of pathology 1992;140(4):839-45.
1992: A Roberts; B Lang; Angela Vincent; John Newsom-Davis
Search for cross-reactive idiotypes on monoclonal and myasthenia gravis acetylcholine receptor antibodies.
Autoimmunity 1992;12(1):53-60.
1992: Andrew G Demaine; Nick Willcox; M Janer; K Welsh; John Newsom-Davis
Immunoglobulin heavy chain gene associations in myasthenia gravis: new evidence for disease heterogeneity.
Journal of neurology 1992;239(1):53-6.
1991: A Morris; David Beeson; Leslie Jacobson; F Baggi; Angela Vincent; John Newsom-Davis
Two isoforms of the muscle acetylcholine receptor alpha-subunit are translated in the human cell line TE671.
FEBS letters 1991;295(1-3):116-8.
1991: Jacqueline Palace; C M Wiles; John Newsom-Davis
3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia.
Journal of neurology, neurosurgery, and psychiatry 1991;54(12):1069-72.
1991: T Yamamoto; Angela Vincent; T A Ciulla; Bethan Lang; I Johnston; John Newsom-Davis
Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
Annals of neurology 1991;30(4):550-7.
1991: B Ong; Nick Willcox; P Wordsworth; David Beeson; Angela Vincent; D Altmann; J S Lanchbury; G C Harcourt; John I Bell; John Newsom-Davis
Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(16):7343-7.
1991: Nick Willcox; M Schluep; M A Ritter; John Newsom-Davis
The thymus in seronegative myasthenia gravis patients.
Journal of neurology 1991;238(5):256-61.
1991: N Sommer; G C Harcourt; Nick Willcox; David Beeson; John Newsom-Davis
Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients.
Neurology 1991;41(8):1270-6.
1991: S Sinha; John Newsom-Davis; K Mills; N Byrne; Bethan Lang; Angela Vincent
Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome)
Lancet 1991;338(8759):75-7.
1991: M Squier; C Chalk; D Hilton-Jones; Kerry R Mills; John Newsom-Davis
Type 2 fiber predominance in Lambert-Eaton myasthenic syndrome.
Muscle & nerve 1991;14(7):625-32.
1991: John Newsom-Davis; K Leys; Angela Vincent; I Ferguson; G Modi; K Mills
Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients.
Journal of neurology, neurosurgery, and psychiatry 1991;54(5):452-3.
1991: K Leys; Bethan Lang; I Johnston; John Newsom-Davis
Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Annals of neurology 1991;29(3):307-14.
1990: C H Chalk; N M Murray; John Newsom-Davis; J H O'Neill; S G Spiro
Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma.
Neurology 1990;40(10):1552-6.
1990: Angela Vincent; David Beeson; John Newsom-Davis
alpha-neurotoxin binding to the human nicotinic acetylcholine receptor.
Biochemical Society transactions 1990;18(5):889-90.
1990: N Sommer; Nick Willcox; G C Harcourt; John Newsom-Davis
Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells.
Annals of neurology 1990;28(3):312-9.
1990: David Beeson; Steve Jeremiah; L F West; Sue Povey; John Newsom-Davis
Assignment of the human nicotinic acetylcholine receptor genes: the alpha and delta subunit genes to chromosome 2 and the beta subunit gene to chromosome 17.
Annals of human genetics 1990;54(Pt 3):199-208.
1990: R P Gregory; L Loh; John Newsom-Davis
Recurrent isolated alternating phrenic nerve palsies: a variant of brachial neuritis?
Thorax 1990;45(5):420-1.
1990: C Peers; B Lang; John Newsom-Davis; D W Wray
Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line.
The Journal of physiology 1990;421():293-308.
1990: John Newsom-Davis
Diseases of the myoneural junction.
Research publications - Association for Research in Nervous and Mental Disease 1990;68():233-40.
1989: Nick Willcox; M Schluep; N Sommer; D Campana; G Janossy; A N Brown; John Newsom-Davis
Variable corticosteroid sensitivity of thymic cortex and medullary peripheral-type lymphoid tissue in myasthenia gravis patients: structural and functional effects.
The Quarterly journal of medicine 1989;73(271):1071-87.
1989: A C Jermy; C A Fisher; Angela Vincent; Nick Willcox; John Newsom-Davis
Experimental autoimmune myasthenia gravis induced in mice without adjuvant: genetic susceptibility and adoptive transfer of weakness.
Journal of autoimmunity 1989;2(5):675-88.
1989: John Newsom-Davis; G Harcourt; David Beeson
Myasthenia gravis: nicotinic acetylcholine receptors as targets for autoimmune attack.
Biochemical Society transactions 1989;17(4):635-7.
1989: David Beeson; M Brydson; John Newsom-Davis
Nucleotide sequence of human muscle acetylcholine receptor beta-subunit.
Nucleic acids research 1989;17(11):4391.
1989: John Newsom-Davis; G Harcourt; N Sommer; David Beeson; Nick Willcox; J B Rothbard
T-cell reactivity in myasthenia gravis.
Journal of autoimmunity 1989;2 Suppl():101-8.
1989: B Lang; Angela Vincent; N M Murray; John Newsom-Davis
Lambert-Eaton myasthenic syndrome: immunoglobulin G inhibition of Ca2+ flux in tumor cells correlates with disease severity.
Annals of neurology 1989;25(3):265-71.
1989: S Lande; J Black; J O Dolly; B Lang; John Newsom-Davis; D W-Wray
Effects of botulinum neurotoxin and Lambert-Eaton myasthenic syndrome IgG at mouse nerve terminals.
Journal of neural transmission. Parkinson's disease and dementia section 1989;1(3):229-42.
1989: Andrew G Engel; A Nagel; T Fukuoka; H Fukunaga; M Osame; B Lang; John Newsom-Davis; Angela Vincent; D W Wray; C Peers
Motor nerve terminal calcium channels in Lambert-Eaton myasthenic syndrome. Morphologic evidence for depletion and that the depletion is mediated by autoantibodies.
Annals of the New York Academy of Sciences 1989;560():278-90.
1989: D W Wray; B Lang; John Newsom-Davis; C Peers
Antibodies against calcium channels in the Lambert-Eaton myasthenic syndrome.
Annals of the New York Academy of Sciences 1989;560():269-77.
1988: F Heidenreich; Angela Vincent; Nick Willcox; John Newsom-Davis
Anti-acetylcholine receptor antibody specificities in serum and in thymic cell culture supernatants from myasthenia gravis patients.
Neurology 1988;38(11):1784-8.
1988: B Lang; John Newsom-Davis; D W Wray
The effect of Lambert-Eaton myasthenic syndrome antibody on slow action potentials in mouse cardiac ventricle.
Proceedings of the Royal Society of London. Series B, Containing papers of a Biological character. Royal Society (Great Britain) 1988;235(1278):103-10.
1988: M Schluep; Nick Willcox; M A Ritter; John Newsom-Davis; M Larché; A N Brown
Myasthenia gravis thymus: clinical, histological and culture correlations.
Journal of autoimmunity 1988;1(5):445-67.
1988: G C Harcourt; N Sommer; J Rothbard; H N Willcox; John Newsom-Davis
A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.
The Journal of clinical investigation 1988;82(4):1295-300.
1988: R Walker; Angela Vincent; John Newsom-Davis
Immunological and pharmacological heterogeneity of alpha-bungarotoxin binding sites extracted from TE671 cells.
Journal of neuroimmunology 1988;19(1-2):149-57.
1988: B Lang; G Richardson; J Rees; Angela Vincent; John Newsom-Davis
Plasma from myasthenia gravis patients reduces acetylcholine receptor agonist-induced Na+ flux into TE671 cell line.
Journal of neuroimmunology 1988;19(1-2):141-8.
1988: J H O'Neill; N M Murray; John Newsom-Davis
The Lambert-Eaton myasthenic syndrome. A review of 50 cases.
Brain : a journal of neurology 1988;111 ( Pt 3)():577-96.
1988: Kerry A Chester; B Lang; J Gill; Angela Vincent; John Newsom-Davis
Lambert-Eaton syndrome antibodies: reaction with membranes from a small cell lung cancer xenograft.
Journal of neuroimmunology 1988;18(2):97-104.
1988: J O Dolly; M Gwilt; G Lacey; John Newsom-Davis; Angela Vincent; P Whiting; D W Wray
Action of antibodies directed against the acetylcholine receptor on channel function at mouse and rat motor end-plates.
The Journal of physiology 1988;399():577-89.
1988: S Mossman; Angela Vincent; John Newsom-Davis
Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect.
Journal of the neurological sciences 1988;84(1):15-28.
1988: F Heidenreich; Angela Vincent; John Newsom-Davis
Differences in fine specificity of anti-acetylcholine receptor antibodies between subgroups of spontaneous myasthenia gravis of recent onset, and of penicillamine induced myasthenia.
Autoimmunity 1988;2(1):31-7.
1988: Andrew G Demaine; Nick Willcox; K Welsh; John Newsom-Davis
Associations of the autoimmune myasthenias with genetic markers in the immunoglobulin heavy chain region.
Annals of the New York Academy of Sciences 1988;540():266-8.
1988: B Lang; N Nagvekar; J Gill; Angela Vincent; John Newsom-Davis
Expression of voltage-gated calcium channels in tumor cell lines of neuroectodermal or other origin.
Annals of the New York Academy of Sciences 1988;540():389-91.
1988: John Newsom-Davis
Lambert-Eaton myasthenic syndrome: a review.
Monographs in allergy 1988;25():116-24.
1988: F Heidenreich; Angela Vincent; A Roberts; John Newsom-Davis
Epitopes on human acetylcholine receptor defined by monoclonal antibodies and myasthenia gravis sera.
Autoimmunity 1988;1(4):285-97.
1988: G Harcourt; N Sommer; J Rothbard; David Beeson; Nick Willcox; John Newsom-Davis
Blood and thymic lymphocyte responses to peptide sequences of the acetylcholine receptor in myasthenia gravis.
Annals of the New York Academy of Sciences 1988;540():354-6.
1987: H C Chiu; Angela Vincent; John Newsom-Davis; K H Hsieh; T Hung
Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians.
Neurology 1987;37(12):1854-7.
1987: B Lang; John Newsom-Davis; C Peers; C Prior; D W Wray
The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse.
The Journal of physiology 1987;390():257-70.
1987: M Schluep; Nick Willcox; Angela Vincent; G K Dhoot; John Newsom-Davis
Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study.
Annals of neurology 1987;22(2):212-22.
1987: T Fukuoka; Andrew G Engel; B Lang; John Newsom-Davis; C Prior; D W Wray
Lambert-Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones.
Annals of neurology 1987;22(2):193-9.
1987: T Fukuoka; Andrew G Engel; B Lang; John Newsom-Davis; Angela Vincent
Lambert-Eaton myasthenic syndrome: II. Immunoelectron microscopy localization of IgG at the mouse motor end-plate.
Annals of neurology 1987;22(2):200-11.
1987: Nick Willcox; M Schluep; M A Ritter; H J Schuurman; John Newsom-Davis; B Christensson
Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset?
The American journal of pathology 1987;127(3):447-60.
1987: Andrew G Engel; T Fukuoka; B Lang; John Newsom-Davis; Angela Vincent; D Wray
Lambert-Eaton myasthenic syndrome IgG: early morphologic effects and immunolocalization at the motor endplate.
Annals of the New York Academy of Sciences 1987;505():333-45.
1987: John Newsom-Davis; Nick Willcox; M Schluep; G Harcourt; Angela Vincent; S Mossman; D Wray; J Burges
Immunological heterogeneity and cellular mechanisms in myasthenia gravis.
Annals of the New York Academy of Sciences 1987;505():12-26.
1987: D W Wray; C Peers; B Lang; S Lande; John Newsom-Davis
Interference with calcium channels by Lambert Eaton myasthenic syndrome antibody.
Annals of the New York Academy of Sciences 1987;505():368-76.
1987: Angela Vincent; P J Whiting; M Schluep; F Heidenreich; B Lang; A Roberts; Nick Willcox; John Newsom-Davis
Antibody heterogeneity and specificity in myasthenia gravis.
Annals of the New York Academy of Sciences 1987;505():106-20.
1986: P J Whiting; Angela Vincent; M Schluep; John Newsom-Davis
Monoclonal antibodies that distinguish between normal and denervated human acetylcholine receptor.
Journal of neuroimmunology 1986;11(3):223-35.
1985: Nick Willcox; M Schluep; M Bofill; John Newsom-Davis
Isolation of germinal centre (GC) cells is greatly improved by using the protease dispase to prepare cell suspensions.
Advances in experimental medicine and biology 1985;186():979-84.
1983: S Wilson; Angela Vincent; John Newsom-Davis
Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. II. Receptor synthesis.
Journal of neurology, neurosurgery, and psychiatry 1983;46(5):383-7.
1983: S Wilson; Angela Vincent; John Newsom-Davis
Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. I. Receptor degradation.
Journal of neurology, neurosurgery, and psychiatry 1983;46(5):377-82.